MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Altimmune Total Current Liabilities 2011-2025 | ALT
Annual Total Current Liabilities Altimmune
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.5 M | 12.1 M | 17.1 M | 18.3 M | 12 M | 3.92 M | 4.53 M | 3.84 M | 205 M | 2.18 M | 2.58 M | 6.8 M | 7.49 M | 4.62 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 205 M | 2.18 M | 22.2 M |
Total Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Arbutus Biopharma Corporation
ABUS
|
22.5 M | $ 4.77 | 1.27 % | $ 792 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
31.6 M | $ 3.33 | 2.61 % | $ 257 M |  USA |
 |
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | USA |
 |
Aptorum Group Limited
APM
|
4.34 M | $ 1.31 | 0.85 % | $ 7.14 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
BioVie
BIVI
|
2.27 M | $ 1.43 | -1.7 % | $ 2.11 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
72.8 M | - | -15.15 % | $ 60.3 M |  Britain |
 |
Aeglea BioTherapeutics
AGLE
|
54.1 M | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
174 M | $ 25.93 | 2.61 % | $ 1.26 B | USA |
 |
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | USA |
 |
Anika Therapeutics
ANIK
|
31.1 M | $ 9.58 | 0.21 % | $ 140 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.05 M | $ 0.28 | -1.82 % | $ 609 M |  Israel |
 |
Arena Pharmaceuticals
ARNA
|
66.3 M | - | -6.81 % | $ 3.04 B | USA |
 |
Catalyst Biosciences
CBIO
|
20 M | $ 14.27 | 1.28 % | $ 939 M | USA |
 |
Athersys
ATHX
|
29.9 M | - | 3.77 % | $ 22.4 M | USA |
 |
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M | USA |
 |
Avenue Therapeutics
ATXI
|
816 K | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
6.35 M | - | 1083.1 % | $ 745 M | USA |
 |
Axon Enterprise
AXON
|
1.68 B | $ 563.27 | -0.18 % | $ 42.7 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
63.1 M | $ 2.33 | 1.3 % | $ 14.6 M | USA |
 |
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
1.66 M | - | -5.38 % | $ 6.06 M | USA |
 |
BeiGene, Ltd.
BGNE
|
2.21 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
534 M | $ 11.68 | 1.26 % | $ 755 M | USA |
 |
Biogen
BIIB
|
5.53 B | $ 171.54 | -1.47 % | $ 25 B | USA |
 |
Abeona Therapeutics
ABEO
|
13.4 M | $ 5.34 | -0.37 % | $ 114 M | USA |
 |
ADiTx Therapeutics
ADTX
|
23.4 M | $ 2.11 | -5.61 % | $ 27.8 K | USA |
 |
Cellectar Biosciences
CLRB
|
25.4 M | $ 3.6 | -0.55 % | $ 44 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
3.77 M | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
45.5 M | - | -7.31 % | $ 87 M | USA |
 |
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | USA |
 |
Завод ДИОД
DIOD
|
105 M | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
1.02 B | - | - | - | Russia |